Drug companies are still raising prices for brand-name prescription medicines, just not as often or by as much as they used to, according to an Associated Press analysis.
The Seattle Children’s Hospital has avoided federal punishment after fixing the cause of mold infections in its patients. The Seattle Times reported that the Centers for Medicare and Medicaid Services announced it will not terminate its program agreement after the hospital upgraded its air-filtration system attributed to mold infections in patients earlier this year. Health officials say 14 operating rooms were closed after Aspergillus mold sickened more than five patients.
U.S. regulators have approved a new tuberculosis medicine that shortens and improves treatment for the hardest-to-treat cases, a worsening problem in many poor countries.
A small but growing number of physicians are discussing publicly their concerns about climate change and environmental factors impacting people’s health. They include some physicians in Spokane seeing impacts from a growing number of regional wildfires and hazardous air quality.
While it’s not so smart to rely on Dr. Google, a growing number of tools via your smarthphone is helping to track, manage and detect health issues.
Spokane’s Mary Ann Wilson, founder of the “Sit and Be Fit” public television show, has received recognition as a 2019 recipient of the President’s Council on Sports, Fitness & Nutrition Community Leadership Award.
Patients are about to be enrolled in the first study to test gene editing inside the body to try to cure an inherited form of blindness.
What are essentials to pack in a gym bag if you’re going from an early morning workout, then directly to work, or maybe to a lunchtime workout? Fitness fans pack smart the night before and keep a small bag of travel toiletries. Baby wipes and dry shampoos are popular, too.
The U.S. Food and Drug Administration has approved the first generic copies of a popular pill for nerve pain. The agency on Monday said it approved nine generic versions of Pfizer Inc.’s Lyrica.
A new study finds shortening hours for doctors during residency training hasn’t harmed patients. Researchers wanted to know whether limiting trainee doctors to 80-hour weeks affected the quality of care.
Spokane-area health care providers explain their infection controls, following report that one patient died and five others were infected by mold in operating rooms at Seattle Children’s Hospital in the past year.
As the climate changes and wildfires are becoming more frequent, data and studies are starting to demonstrate how wildfire smoke can have adverse health effects, even for those who are miles away from the fire.
Sales of biosimilars, cheaper near-copies of pricey biologic drugs, have been so limited in the U.S. that their future is in doubt.
Since 2018, a Spokane biomedical research company has waded into multiple clinical trials to find treatments to slow or more effectively fight neurological conditions such as Parkinson’s disease. With more than 100 participants so far, the studies are at Inland Northwest Research, owned by neurologist Dr. Jason Aldred, and also looking at Huntington’s disease, Lou Gehrig’s disease and multiple sclerosis.
U.S. women will soon have another drug option designed to boost low sex drive: a shot they can give themselves in the thigh or abdomen that raises sexual interest for several hours.
More than 1 million people worldwide are infected daily by sexually transmitted infections chlamydia, gonorrhea, trichomoniasis and syphilis, according to World Health Organization estimates.
Health officials in Idaho on Wednesday confirmed a measles case in Latah County, the first in the state since 2001.
The results were from an analysis of hundreds of thousands of insurance claims. Verifying that the drug would actually have that effect in people would require a costly clinical trial – and after several years of internal discussion, Pfizer opted against further investigation and chose not to make the data public, the company confirmed.
U.S. regulators have approved the most expensive medicine ever, a $2.125 million gene therapy meant to cure a disorder that rapidly destroys a baby’s muscle control and kills most within a couple years.